IE45197L - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- IE45197L IE45197L IE771001A IE100177A IE45197L IE 45197 L IE45197 L IE 45197L IE 771001 A IE771001 A IE 771001A IE 100177 A IE100177 A IE 100177A IE 45197 L IE45197 L IE 45197L
- Authority
- IE
- Ireland
- Prior art keywords
- pharmaceutical composition
- etilefrin
- ergot alkaloid
- ca1088865a
- venotonics
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- SQVIAVUSQAWMKL-UHFFFAOYSA-N 3-[2-(ethylamino)-1-hydroxyethyl]phenol Chemical compound CCNCC(O)C1=CC=CC(O)=C1 SQVIAVUSQAWMKL-UHFFFAOYSA-N 0.000 abstract 2
- 229960003133 ergot alkaloid Drugs 0.000 abstract 2
- 229960004695 etilefrine Drugs 0.000 abstract 2
- HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 abstract 1
- 229960004704 dihydroergotamine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001643 venotonic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
PHARMACEUTICAL COMPOSITION CONTAINING A HYDROGENATED ERGOT ALKALOID AND ETILEFRIN The invention provides novel pharmaceutical compositions useful as venotonics, comprising a mixture of dihydroergotamine or a related ergot alkaloid and etilefrin.
[CA1088865A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762621906 DE2621906A1 (en) | 1976-05-17 | 1976-05-17 | NEW THERAPEUTIC MIXTURE AND METHOD FOR PRODUCING IT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE45197L true IE45197L (en) | 1977-11-17 |
| IE45197B1 IE45197B1 (en) | 1982-07-14 |
Family
ID=5978199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1001/77A IE45197B1 (en) | 1976-05-17 | 1977-05-16 | Improvements in or relating to organic compounds |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS52139730A (en) |
| AT (1) | AT366574B (en) |
| AU (1) | AU513718B2 (en) |
| BE (1) | BE854694A (en) |
| CA (1) | CA1088865A (en) |
| CS (1) | CS207455B2 (en) |
| DE (1) | DE2621906A1 (en) |
| ES (1) | ES458819A1 (en) |
| FR (1) | FR2351657A1 (en) |
| GB (1) | GB1565447A (en) |
| GR (1) | GR72995B (en) |
| HK (1) | HK3283A (en) |
| HU (1) | HU175167B (en) |
| IE (1) | IE45197B1 (en) |
| IL (1) | IL52101A (en) |
| MY (1) | MY8400062A (en) |
| NL (1) | NL177981C (en) |
| NZ (1) | NZ184111A (en) |
| PH (1) | PH20257A (en) |
| PT (1) | PT66552B (en) |
| SE (1) | SE425545B (en) |
| ZA (1) | ZA772935B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2935515A1 (en) * | 1979-09-03 | 1981-03-19 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | MEDICINAL PRODUCT |
| JPH0227013U (en) * | 1988-08-10 | 1990-02-22 | ||
| WO2000057851A2 (en) | 1999-03-26 | 2000-10-05 | Pozen Inc. | High potency dihydroergotamine compositions |
-
1976
- 1976-05-17 DE DE19762621906 patent/DE2621906A1/en active Granted
-
1977
- 1977-05-09 SE SE7705340A patent/SE425545B/en not_active IP Right Cessation
- 1977-05-12 FR FR7714507A patent/FR2351657A1/en active Granted
- 1977-05-13 NL NLAANVRAGE7705306,A patent/NL177981C/en not_active IP Right Cessation
- 1977-05-13 GB GB20210/77A patent/GB1565447A/en not_active Expired
- 1977-05-13 PH PH19768A patent/PH20257A/en unknown
- 1977-05-16 BE BE177623A patent/BE854694A/en not_active IP Right Cessation
- 1977-05-16 AT AT0347677A patent/AT366574B/en not_active IP Right Cessation
- 1977-05-16 NZ NZ184111A patent/NZ184111A/en unknown
- 1977-05-16 ES ES458819A patent/ES458819A1/en not_active Expired
- 1977-05-16 JP JP5624877A patent/JPS52139730A/en active Granted
- 1977-05-16 IE IE1001/77A patent/IE45197B1/en unknown
- 1977-05-16 CS CS773204A patent/CS207455B2/en unknown
- 1977-05-16 CA CA278,488A patent/CA1088865A/en not_active Expired
- 1977-05-16 PT PT66552A patent/PT66552B/en unknown
- 1977-05-16 IL IL52101A patent/IL52101A/en unknown
- 1977-05-16 AU AU25169/77A patent/AU513718B2/en not_active Expired
- 1977-05-16 HU HU77SA3035A patent/HU175167B/en not_active IP Right Cessation
- 1977-05-17 GR GR53485A patent/GR72995B/el unknown
- 1977-05-17 ZA ZA00772935A patent/ZA772935B/en unknown
-
1983
- 1983-01-20 HK HK32/83A patent/HK3283A/en unknown
-
1984
- 1984-12-30 MY MY62/84A patent/MY8400062A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52139730A (en) | 1977-11-21 |
| JPS628413B2 (en) | 1987-02-23 |
| BE854694A (en) | 1977-11-16 |
| AT366574B (en) | 1982-04-26 |
| IL52101A (en) | 1980-01-31 |
| ZA772935B (en) | 1979-01-31 |
| DE2621906A1 (en) | 1977-12-01 |
| MY8400062A (en) | 1984-12-31 |
| SE425545B (en) | 1982-10-11 |
| DE2621906C2 (en) | 1988-04-21 |
| FR2351657A1 (en) | 1977-12-16 |
| GB1565447A (en) | 1980-04-23 |
| NZ184111A (en) | 1980-02-21 |
| CS207455B2 (en) | 1981-07-31 |
| SE7705340L (en) | 1977-11-18 |
| CA1088865A (en) | 1980-11-04 |
| AU2516977A (en) | 1978-11-23 |
| NL177981C (en) | 1986-01-02 |
| ATA347677A (en) | 1981-09-15 |
| IL52101A0 (en) | 1977-07-31 |
| IE45197B1 (en) | 1982-07-14 |
| HU175167B (en) | 1980-05-28 |
| ES458819A1 (en) | 1978-08-01 |
| NL7705306A (en) | 1977-11-21 |
| FR2351657B1 (en) | 1980-01-18 |
| PT66552B (en) | 1979-09-03 |
| GR72995B (en) | 1984-01-24 |
| PT66552A (en) | 1977-06-01 |
| HK3283A (en) | 1983-01-20 |
| AU513718B2 (en) | 1980-12-18 |
| NL177981B (en) | 1985-08-01 |
| PH20257A (en) | 1986-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE781716L (en) | Trihydroxypiperidine compounds | |
| AU3078377A (en) | Nasal ergot alkaloid compositions | |
| IE780932L (en) | Cyclosporins (cyclic polypeptides) | |
| EG12773A (en) | Processes for the preparation of amidinoureas,the amidinoureas thus produced and compositions incorporating them | |
| IE790622L (en) | Carbamic and thiocarbamic acid derivatives | |
| IE782475L (en) | Compounds | |
| AU508628B2 (en) | Ergot alkaloid compositions | |
| DE3069771D1 (en) | Novel ergoline derivatives, compositions containing them, their preparation and use as pharmaceuticals | |
| AU502957B2 (en) | Oxadiazolinone derivatives and insecticidal compositions containing them | |
| IL54238A (en) | Beta-endorphin analogues,their preparation and pharmaceutical compositions containing them | |
| KE3232A (en) | 2-formylquinoxaline-1,4-dioxide cyanoacetylhydrazones,processes for the preparation thereof and compositions containing same | |
| IL61614A (en) | Ergoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IE44427L (en) | Benzothiadiazole containing composition | |
| IL55315A0 (en) | New 4-hydroxy-2-benzimidazolinone derivatives,processes for the preparation thereof and pahrmaceutical compositions containing the same | |
| JPS5328145A (en) | Substituted benzoyllureidodiphenylether* process for manufacture thereof and arthropodaakilling composition containing it as active ingredient | |
| IE45197L (en) | Pharmaceutical composition | |
| AU534051B2 (en) | Ergot alkaloid slow-release compositions | |
| IL61222A0 (en) | Ergot peptide alkaloids, their production and pharmaceutical compositions containing them | |
| AU499139B2 (en) | Slow-release composition containing phentolamine | |
| IL53030A (en) | Derivatives of 9-chloroprednisolone,processes for their preparation and pharmaceutical compositions containing the same | |
| AU509855B2 (en) | Compositions of 1, 2, 4-rhiadiazine derivatives | |
| JPS5344565A (en) | Novel n*nndimethylloopyrazolyllcarbamate* its preparation and incecticidal composition containing same as active ingredient | |
| JPS56156279A (en) | Ergoline derivative, its manufacture and medicinal composition containing it | |
| IL60287A0 (en) | Ergot peptide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL56457A0 (en) | Ergot peptide alkaloid derivatives, their preparation and pharmaceutical compositions containing them |